Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $13.06 Analyst target: $17.80 Upside: 36.29%
Alpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development, and commercialization of alpha-emitting radiation therapy (Alpha DaRT) for the treatment of solid cancer in Israel and the United States. The company is headquartered in Jerusalem, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.